is fda banning compounded semaglutide Fifth Circuit probes ban on GLP-1s Safe use of compounded GLP

High-dose GHRP-6: Moderate-high risk Why it's concerning: Significant appetite increase (can derail diet) Prolactin elevation (gynecomastia risk in sensitive individuals) Cortisol increase at high doses Water retention When it might be acceptable: Moderate doses (100-200mcg, not 300+mcg) Short-term use (8-12 weeks) If appetite increase isn't problematic Safer alternatives: Ipamorelin (no prolactin/cortisol increase) Lower GHRP-6 doses with careful monitoring Hexarelin: Higher risk than benefits justify Why it's problematic: Rapid desensitization (must cycle frequently) Cortisol and prolactin elevation Heart stress concerns Diminishing returns Limited use cases: Very short cycles (4 weeks maximum) Experienced users only With careful monitoring Better options: Ipamorelin for sustained results GHRP-2 for middle ground Synthetic growth hormone: Highest overall risk Why avoid: Complete shutdown of natural GH production Organ growth (hands, feet, jaw, internal organs) Insulin resistance Expensive Requires PCT (post-cycle therapy) Legal issues in most countries Only justified for: Medical growth hormone deficiency Under physician supervision Replacement doses, not supraphysiological Much safer alternatives: CJC-1295 + Ipamorelin stack Natural peptides that stimulate endogenous GH No shutdown, no PCT needed See peptides vs steroids and peptides vs SARMs for safety comparisons

10.1001/archgenpsychiatry.2010.2 Arch

Side effects Common side effects of this drug are: Mild stomach upset (stomach cramps or loose motions) The child may feel sick (mild in nature) Fishy smell from the body due to the medicine (not very common) It may take longer time than usual for the blood to clot if you are taking any anti-clotting medicines like Warfarin Precautions and Warnings Pregnancy This medicine is intended to be used in children, infants and newborns below 12 years of age

Hershman DL, Unger JM, Crew KD, et al

Yong, K